Case Report
Copyright ©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Feb 7, 2013; 19(5): 769-772
Published online Feb 7, 2013. doi: 10.3748/wjg.v19.i5.769
Degarelix as a new antiangiogenic agent for metastatic colon cancer?
Francois Ghiringhelli, Nicolas Isambert, Sylvain Ladoire
Francois Ghiringhelli, Nicolas Isambert, Sylvain Ladoire, Unite Mixte de Recherche 866, Institut National de la Sante et de la Recherche Medicale/Universite de Bourgogne, 21000 Dijon, France
Francois Ghiringhelli, Nicolas Isambert, Sylvain Ladoire, Departement of Oncologie Medicale, Centre Georges Francois Leclerc, 21000 Dijon, France
Author contributions: Ghiringhelli F, Isambert N and Ladoire S contributed to write and revise the paper.
Correspondence to: Francois Ghiringhelli, MD, PhD, Departement of Oncologie Medicale, Centre Georges Francois Leclerc, 1 rue du Professeur Marion, 21000 Dijon, France. fghiringhelli@cgfl.fr
Telephone: +33-3-8393353 Fax: +33-3-8393434
Received: August 31, 2012
Revised: December 18, 2012
Accepted: December 22, 2012
Published online: February 7, 2013
Core Tip